Stay Informed While Earning Psoriatic Arthritis CME Credits
Psoriatic arthritis (PsA) is a serious and potentially disabling condition that affects about 30% of patients with psoriasis. The joint involvement of PsA often occurs about 10 years after the appearance of skin disease. In addition to the physical and functional impairments from joint destruction, PsA negatively impacts relationships, activities of daily living, work productivity, and overall quality of life (QoL). Unfortunately, individuals with PsA are often undiagnosed or misdiagnosed. Dermatologists clearly have an important role in detecting early signs of PsA, and the overlapping treatment needs of patients often require collaborative care between dermatologists and rheumatologists.
This Psoriatic Arthritis Hub is dedicated to providing educational activities, resources, and tools to improve the care of patients with PsA.
Why New Treatments are Needed for the Management of Psoriasis
|
|
This CME Outfitters Snack will evaluate the factors that are associated with patient perspectives on disease burden, address that burden, and the unmet treatment needs in the management of PsO, in order to show why new treatments are needed. |
Refining Treatment Targets for the Management of Psoriasis
|
|
In this CME Outfitters Snack, expert faculty evaluate the role of TYK2 versus JAK1, JAK2, and JAK3 signaling pathways in PsO as the differences in mechanisms of action offer new and effective options for patients with PsO. |
Forecasting a Bright and Clear Tomorrow for Psoriasis Treatment
|
|
This CME Outfitters Snack will focus on evaluating the efficacy and safety data for these emerging therapies, and on engaging patients in discussion about their treatment goals to improve treatment choices. |
Differentiating Psoriasis in Skin of Color
|
|
The first episode of this four-episode CME Outfitters BriefCase learning series includes a video clinical encounter on differentiating PsO in people with skin of color, based on notable differences in disease presentation. |
The Importance of Care Coordination for Patients with Psoriatic Arthritis
|
|
The third episode of this BriefCase series on challenging cases in PsO and PsA features a physician-patient office scenario video on educating the patient and strategies to coordinate care between specialists, as well as between specialists and primary care, with a goal of optimizing patient outcomes. |
Comprehensive and Coordinated Patient-Centered Care in Psoriatic Arthritis
|
|
This CMEOCast podcast on psoriatic arthritis (PsA) focuses on how clinicians can collaborate with each other and with their patients in order to optimize treatment regimens across the health care continuum. Access the transcript from the podcast Comprehensive and Coordinated Patient-Centered Care in Psoriatic Arthritis, featuring Dr. Allan Gibofsky and Dr. April Armstrong. |
Improving Outcomes for Patients with Psoriatic Arthritis: Integrating a Comprehensive, Patient-Centered Care Model into Your Practice
|
|
In this CMEOCast podcast, expert faculty focus on the latest evidence on screening patients for PsA, individualizing treatment that considers patient-reported outcomes (PROs), and using patient-centered approaches for care, with the goal of optimizing patient outcomes. |
Clinician Resources
Reading Room
- Husni ME, Merola JF, Davin S. The psychosocial burden of psoriatic arthritis. Semin Arthritis Rheum. 2017;47:351-360.
- Zhang A, Kurtzman DJB, Perez-Chada LM, Merola JF. Psoriatic arthritis and the dermatologist: an approach to screening and clinical evaluation. Clin Dermatol.2018;36:551-560.
- Elalouf O, Chandran V. Novel therapeutics in psoriatic arthritis: what is in the pipeline? Curr Rheumatol Rep.2018;20:36.
- Merola JF, Espinoza LR, Fleischmann R. Distinguishing rheumatoid arthritis from psoriatic arthritis. RMD Open.2018;4:e000656.
- Gossec L, Coates LC, de Wit M, et al. Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations. Nat Rev Rheumatol.2016;12:743-750.
- Coates LC, Kavanaugh A, Mease PJ, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis. Arthritis Rheumatol.2016;68:1060-1071.
- Gossec L, Smolen JS, Ramiro S, et al. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis.2016;75:499-510.
Discover additional accredited CME/CE activities and patient resources on the Virtual Education Hub.